Grown Rogue International (GRUSF) Debt Ratio (2009 - 2026)

Grown Rogue International (GRUSF) posted quarterly Debt Ratio of 0.15 for Q1 2026, down 5.7% quarter-over-quarter from 0.16 in Q4 2025.

Grown Rogue International (GRUSF) Debt Ratio (2009 - 2026) Analysis & Trends

Grown Rogue International's Debt Ratio history runs 17 years deep, the most recent figure standing at 0.15 for Q1 2026.

In Q1 2026, Debt Ratio changed N/A year-over-year to 0.15; the TTM figure through Mar 2026 stood at 0.15 (changed N/A YoY), while the FY2025 annual figure was 0.16, changed N/A from the prior year.
Debt Ratio for Q1 2026 stood at 0.15, down from 0.16 in the prior quarter.
The five-year high for Debt Ratio was 0.19 in Q3 2025, with the low at 0.0 in Q4 2023.
The 5-year median for Debt Ratio is 0.04 (2024), against an average of 0.07.
Peak annual rise in Debt Ratio reached 399.79% in 2025, while the deepest fall reached 399.79% in 2025.
Grown Rogue International's Debt Ratio stood at 0.05 in 2022, then plunged by 94.58% to 0.0 in 2023, then jumped by 1241.92% to 0.04 in 2024, then soared by 328.03% to 0.16 in 2025, then dropped by 5.7% to 0.15 in 2026.
Business Quant data shows GRUSF's Debt Ratio at 0.15 in Q1 2026, 0.16 in Q4 2025, and 0.19 in Q3 2025.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Haleon	43.94 Bn	42.97 Bn	-	-0.13
2	Teva Pharmaceutical Industries	42.95 Bn	39.30 Bn	2.15 Bn	0.42
3	Zoetis	31.58 Bn	29.90 Bn	1.05 Bn	0.60
4	Takeda Pharmaceutical	28.63 Bn	22.83 Bn	5.10 Bn	0.32
5	United Therapeutics	22.16 Bn	19.49 Bn	683.80 Mn	-
6	Viatris	18.75 Bn	17.86 Bn	1.46 Bn	0.38
7	Neurocrine Biosciences	15.53 Bn	15.14 Bn	935.80 Mn	-
8	Elanco Animal Health	11.76 Bn	11.23 Bn	798.00 Mn	0.29
9	Dr Reddys Laboratories	10.11 Bn	9.95 Bn	-	0.12
10	Grown Rogue International	110.47 Mn	98.93 Mn	5.37 Mn	0.15

Download Data